Related Experiment Video
Updated: Sep 13, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Toward Personalized Decision Support Systems for Type 1 Diabetes: Integrating Psychobehavioral Factors and Glycemic
Mohammadreza Ganji1, Leela Krishna Chaitanya Koravi1, Marc Breton1
1Center for Diabetes Technology, University of Virginia, Charlottesville, VA, USA.
Background:
While novel technologies have improved glycemic control in type 1 diabetes (T1D), their design is often glucose-centric and overlooks critical psychobehavioral elements such as individual treatment preferences and therapeutic goals. This article presents an algorithm development framework and study layout aimed at incorporating psychobehavioral factors into the design of technology for the management of T1D.
Methods/Design:
A decision support system (DSS) was engineered at the University of Virginia providing therapeutic advice to individuals with T1D regarding optimal insulin dosing parameters, bolus calculation, safe undertaking of physical activity, and risk for hypoglycemia during the day as well as at bedtime. To accommodate individual preferences as to how the therapeutic advice is delivered, the DSS was designed with two possible operating modalities: prescriptive-offering optimized therapeutic recommendations for structured guidance, and informative-providing users with actionable insights to support informed decision-making. To test the DSS, a randomized crossover clinical trial design is described, where participants are sequentially exposed to each modality in random order. Throughout the study, glycemic control is captured by continuous glucose monitors, while patient-reported outcomes are assessed through psychometric evaluations.
Conclusion:
This work introduces a novel framework for the design of personalized DSS technology capable of tailoring the delivery mode of therapeutic insights to each user's preferences. By integrating psychobehavioral factors into algorithm design, this work seeks to advance the development of adaptive, user-centric technologies that can enhance both clinical outcomes and patient quality of life.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

